POSTN and non-small cell lung carcinoma: Our study findings indicated that protein expressions of integrin-αvβ3 and PI3K/pAKT were reduced in the cells representing the loss-of-function phenotype (A549.shRNA) compared to control cells, indicating the silencing of POSTN in the integrin-signaling pathway during the course of NSCLC.